Dh. Shin et al., DECREASE OF CAPSULAR OPACIFICATION WITH ADJUNCTIVE MITOMYCIN-C IN COMBINED GLAUCOMA AND CATARACT-SURGERY, Ophthalmology (Rochester, Minn.), 105(7), 1998, pp. 1222-1226
Objective: The authors investigated the incidence of capsular opacific
ation requiring YAG capsulotomy after primary trabeculectomy combined
with phacoemulsification and implantation of all polymethylmethacrylat
e intraocular lenses. Design: A prospective randomized study. Particip
ants: One hundred seventy-four eyes of 174 nonselected patients with p
rimary open-angle glaucoma (POAG) were randomized to either no adjunct
ive mitomycin C (MMC) (control group of 93 eyes of 93 patients) or adj
unctive subconjunctival MMC (MMC group of 81 eyes of 81 patients) duri
ng the primary glaucoma triple procedure (PGTP). Intervention: Primary
glaucoma triple procedure with and without MMC and YAG laser capsulot
omy for posterior capsular opacification (PCO) was performed. Main Out
come Measures: The incidences of YAG capsulotomy for PCO were compared
between the control and MMC groups and also between the control group
and the MMC subgroups (1 minute, 3 minutes, and 5 minutes of MMC appl
ication) using Kaplan-Meier analysis with Mantel-Cox log-rank test. Co
x proportional hazard regression analysis also was performed to identi
fy significant factors affecting capsular opacification. Results: The
control and MMC groups were similar in preoperative characteristics. H
owever, the probability of PCO requiring YAG capsulotomy was significa
ntly lower in the MMC group than in the control group (P = 0.004). Amo
ng the MMC subgroups, MMC application for 3 minutes was most effective
and significant when compared with that of the control group (P = 0.0
02). Although not as significant as the intraoperative use of MMC (P =
0.002), old age (P = 0.026) and presence of diabetes mellitus (P = 0.
035) were also identified as significant beneficial factors for decrea
sing the incidence of YAG capsulotomy for PCO in Cox proportional haza
rd regression analysis. Conclusion: Intraoperative subconjunctival MMC
application during combined glaucoma and cataract surgery has a benef
icial effect of inhibiting PCO after combined surgery in patients with
POAG. Thus, after intraoperative subconjunctival application of MMC a
t the concentration of 0.5 mg/ml for 3 minutes, the aqueous MMC level
must have been great enough to inhibit the lens epithelial cell prolif
eration to result in a long-term decrease in PCO.